Literature DB >> 4854893

The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect.

L J Peters, H B Hewitt.   

Abstract

Experiments were undertaken to test a new hypothesis for the mechanism underlying the Révész effect. The hypothesis proposes that lethally irradiated (LI) tumour cells enhance the take probability of a small number of transplanted viable (V) tumour cells mixed with them by exerting a thromboplastic effect at the site of injection; local fibrin formation prevents emigration of V cells from the site or secures their survival there. The evidence presented to support this hypothesis is as follows: in the case of 3 isogeneically transplanted tumours, admixed particulate brain extract simulated the effect of LI cells in increasing the take probability of V cells; brain extract simulated the effect of LI cells in greatly delaying the disappearance of (125)IUdR-labelled viable carcinoma cells from the injection site; V cells acquired a raised take probability by their incorporation in fibrin clots; it was confirmed that admixed erythrocytes increased the take probability of V cells; using a newly devised microscopical test for detection of the thromboplastic activity of individual cells, it was found that cell death was almost always required for the display of such activity; lymphocytes and bone marrow cells, ineffective in enhancing the take of V cells, were almost totally devoid of thromboplastic activity. Possible explanations are given for failure of a fibrinogen depleting agent, ancrod (Arvin) to inhibit the Révész effect when administered to recipients. It is concluded that the evidence strongly supports the hypothesis presented whilst seriously weakening the long-standing theories that admixed LI cells act by provision of nutrients or by local quenching of postulated immune reactivity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4854893      PMCID: PMC2009179          DOI: 10.1038/bjc.1974.68

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  J Natl Cancer Inst       Date:  1964-11       Impact factor: 13.506

2.  Effects of roentgen irradiation on the tumor bed. I. The inhibiting action of local pretransplantation roentgen irradiation (1500 r alpha) on the growth of mouse mammary carcinoma.

Authors:  K W STENSTROM; H VERMUND; D G MOSSER; J F MARVIN
Journal:  Radiat Res       Date:  1955-04       Impact factor: 2.841

3.  Effect of tumour cells killed by x-rays upon the growth of admixed viable cells.

Authors:  L REVESZ
Journal:  Nature       Date:  1956-12-22       Impact factor: 49.962

4.  The clotting activity of human erythrocytes: theoretical and clinical implications.

Authors:  A J QUICK; J G GEORGATSOS; C V HUSSEY
Journal:  Am J Med Sci       Date:  1954-08       Impact factor: 2.378

5.  Sickle-cell anaemia in G.-6-P.D. deficiency.

Authors:  R A Lewis
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

6.  Effects of single doses of radiation on lung metastases in man and experimental animals.

Authors:  H A van Peperzeel
Journal:  Eur J Cancer       Date:  1972-12       Impact factor: 9.162

7.  Defibrination and metastasis formation: effects of arvin on experimental metastases in mice.

Authors:  B Hagmar
Journal:  Eur J Cancer       Date:  1972-02       Impact factor: 9.162

8.  Tumour growth after intravenous, intraperitoneal and subcutaneous injection of syngeneic monodispersed tumour-cell suspension.

Authors:  B Boeryd; P M Lundin; K Norrby
Journal:  Eur J Cancer       Date:  1971-12       Impact factor: 9.162

9.  Biological stability of 5-iodo-2'-deoxyuridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse.

Authors:  S L Commerford
Journal:  Nature       Date:  1965-05-29       Impact factor: 49.962

10.  The effect of lethally irradiated cells on the transplantability of murine tumours.

Authors:  H B Hewitt; E Blake; E H Proter
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more
  15 in total

Review 1.  Are cancer stem cells radioresistant?

Authors:  Walter N Hittelman; Yong Liao; Li Wang; Luka Milas
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

Review 2.  Influence of implantation site on formation of metastases.

Authors:  C Meyvisch
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  An appraisal of in vivo assays of excised tumours.

Authors:  R P Hill
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Lowering of innate resistance of the lungs to the growth of blood-borne cancer cells in states of topical and systemic stress.

Authors:  H A Van Den Brenk; M G Stone; H Kelly; C Sharpington
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

5.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

6.  Clonogenic assays in the B16 melanoma: response to cyclophosphamide.

Authors:  G G Steel; K Adams; T C Stephens
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

7.  Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.

Authors:  L J Peters
Journal:  Br J Cancer       Date:  1975-03       Impact factor: 7.640

8.  Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells.

Authors:  B B Lozzio; E A Machado; C B Lozzio; S Lair
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

9.  Facilitation of nodal metastasis from a non-immunogenic murine carcinoma by previous whole-body irradiation of tumour recipients.

Authors:  H B Hewitt; E R Blake
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

10.  Improved immune-suppression techniques for the exongrafting of human tumours.

Authors:  G G Steel; V D Courtenay; A Y Rostom
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.